Hyperparathyroidism primary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 12: | Line 12: | ||
==Primary Prevention== | ==Primary Prevention== | ||
*Effective measures for the primary prevention of secondary hyperparathyroidism in chronic kidney disease include:<ref name="pmid14520607">{{cite journal| author=National Kidney Foundation| title=K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. | journal=Am J Kidney Dis | year= 2003 | volume= 42 | issue= 4 Suppl 3 | pages= S1-201 | pmid=14520607 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14520607 }} </ref> | |||
**Aggressive management of hyperphosphatemia in early stages of chronic kidney disease | |||
**Prevention and treatment of vitamin D deficiency in stage 3 & 4 chronic kidney disease | |||
*Effective measures for the primary prevention of | |||
** | |||
** | |||
*There are no established measures for the primary prevention of primary hyperparathyroidism. | |||
==References== | ==References== | ||
Revision as of 16:48, 6 September 2017
|
Hyperparathyroidism Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hyperparathyroidism primary prevention On the Web |
|
American Roentgen Ray Society Images of Hyperparathyroidism primary prevention |
|
Risk calculators and risk factors for Hyperparathyroidism primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
- There are no established measures for the primary prevention of [disease name].
- There are no available vaccines against [disease name].
OR
- Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
- [Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].
Primary Prevention
- Effective measures for the primary prevention of secondary hyperparathyroidism in chronic kidney disease include:[1]
- Aggressive management of hyperphosphatemia in early stages of chronic kidney disease
- Prevention and treatment of vitamin D deficiency in stage 3 & 4 chronic kidney disease
- There are no established measures for the primary prevention of primary hyperparathyroidism.
References
- ↑ National Kidney Foundation (2003). "K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease". Am J Kidney Dis. 42 (4 Suppl 3): S1–201. PMID 14520607.